Dinutuximab (anti-GD2) is a chimeric, human-murine, anti-GD2 monoclonal antibody. Dinutuximab (anti-GD2) potently enlongs event-free survival and overall survival, in high-risk neuroblastoma treatment, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]).
Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
- UPC:
- 51121616
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab175510-10mg
- CAS:
- 1363687-32-4
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





